Name: endocrine treatment of breast cancer: a new approach (en Inglés)
Price: 553612.00 COP
Availability: InStock
Author: Henningsen, B. ; Linder, F. ; Steichele, C.
ISBN: 9783642814082

portada endocrine treatment of breast cancer: a new approach (en Inglés)

Formato

Libro Físico

Ilustrado por

Editorial

Autor

Henningsen, B. ; Linder, F. ; Steichele, C.

Año

2011

Idioma

Inglés

N° páginas

228

Encuadernación

Tapa Blanda

Dimensiones

24.4 x 17.0 x 1.3 cm

Peso

0.41 kg.

ISBN

3642814085

ISBN13

9783642814082

Categorías

Oncología
Ginecología y obstetricia
Hacer frente al cáncer

endocrine treatment of breast cancer: a new approach (en Inglés)

B. Henningsen (Ilustrado por) · F. Linder (Ilustrado por) · C. Steichele (Ilustrado por) · Springer · Tapa Blanda

Libro Nuevo

$ 553.612

$ 922.687

Ahorras: $ 369.075

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 20 de Mayo y el Lunes 03 de Junio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "endocrine treatment of breast cancer: a new approach (en Inglés)"

Progress in basic research has made it necessary to redetermine the possibility of classic endocrine therapy for the treatment of patients with breast cancer. Exemplary, close cooperation between biochemis- try and animal and clinical research led to a truly interdisciplinary and international exchange of ideas and experience at a symposium held in autumn 1978 in Heidelberg. We owe our thanks to ICI-Pharma for the kind support of this sym- posIUm. The participation of Charles Huggins in the meeting as honorary chairman signified to all participants the meaning of this joint endeavour. It was the same Charles Huggins who through experimental work laid the foundation stone for endocrine ther- apy of prostate and breast cancer, and who applied his findings clinically. Thousands of patients owe to him relief from their suffering. He contributed greatly to the attempt to find and stabilize the endocrine therapy for breast cancer, for which we thank him sincerely. We hope that the following contributions will similarly serve the well-being of our patients.